KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Depreciation & Amortization (CF): 2010-2015

Historic Depreciation & Amortization (CF) for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2015 value amounting to $43,000.

  • Biocryst Pharmaceuticals' Depreciation & Amortization (CF) rose 7.50% to $43,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $180,000, marking a year-over-year increase of 1.69%. This contributed to the annual value of $1.2 million for FY2024, which is 24.71% down from last year.
  • As of Q4 2015, Biocryst Pharmaceuticals' Depreciation & Amortization (CF) stood at $43,000, which was down 0.00% from $43,000 recorded in Q3 2015.
  • Biocryst Pharmaceuticals' Depreciation & Amortization (CF)'s 5-year high stood at $256,000 during Q4 2011, with a 5-year trough of $40,000 in Q3 2014.
  • Its 3-year average for Depreciation & Amortization (CF) is $55,083, with a median of $47,000 in 2015.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 78.12% in 2011, then grew by 11.36% in 2015.
  • Biocryst Pharmaceuticals' Depreciation & Amortization (CF) (MRQ) stood at $256,000 in 2011, then tumbled by 34.77% to $167,000 in 2012, then crashed by 65.87% to $57,000 in 2013, then dropped by 29.82% to $40,000 in 2014, then rose by 7.50% to $43,000 in 2015.
  • Its last three reported values are $43,000 in Q4 2015, $43,000 for Q3 2015, and $49,000 during Q2 2015.